Rocuronium Composition pH Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current rocuronium compositions are thermally unstable, requiring cold-chain storage and have limited shelf-life at room temperature, which is inconvenient and costly for healthcare providers and manufacturers.

Innovation Solution

An aqueous rocuronium composition with a pH of 2.5 to 3.5 and titratable acidity of not more than 35 mEq, which is stable at room temperature for several years, achieved through pH adjustment using hydrochloric acid and alkalizing agents, and sterilized by thermal or aseptic methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If rocuronium is formulated as an aqueous solution with conventional pH and buffer systems, then it provides adequate stability, but it requires cold-chain storage and has limited shelf-life at room temperature

Engineering Contradiction:
Improvethermal stabilityVSAvoidshelf-life at room temperature
Core Design Contradiction:
Stability of the object's compositionVSDuration of action of stationary object

Solution Approach 1:

The patent applies parameter changes by optimizing the pH to a specific range of 2.5-3.5 and controlling titratable acidity to not more than 35 mEq. This chemical parameter optimization enables the rocuronium composition to achieve both thermal stability and extended shelf-life at room temperature, resolving the contradiction between stability and storage duration without requiring cold-chain storage.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If cold-chain storage is implemented to maintain stability, then degradation is reduced, but storage and transportation costs increase and logistics become more complex

Engineering Contradiction:
Improvedegradation resistanceVSAvoidstorage and transportation logistics
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent enables the rocuronium composition to be self-stabilizing at room temperature through optimized pH (2.5-3.5) and titratable acidity (≤35 mEq) parameters. This eliminates the need for external cold-chain infrastructure and active temperature control systems, allowing the product to maintain stability autonomously under ambient conditions and significantly simplifying storage and transportation logistics.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition maintains stability and effectiveness for at least three years at room temperature, reducing degradation and improving storage and transportation logistics.

Implementation Method 1

The composition has a pH of 2.5 to 3.5 and a titratable acidity of not more than 35 mEq

Methodology Applied
Scientific EffectBuffering:

Data Source

PatentUS20240293428A1Aqueous, room-temperature stable rocuronium composition
Publication Date: 2024.09.05 FRESENIUS KABI AUSTRIA GMBH
  • US20240293428A1 patent drawing
  • US20240293428A1 patent drawing

AI summary

The invention relates to a rocuronium composition providing no or less vascular pain to patients upon injection. The rocuronium composition has a pH of 2.5 to 3.5 and a titratable acidity of not more than 35 mEq. The rocuronium composition is stable upon thermal sterilization. Further, the rocuronium composition is stable upon storage at room-temperature.